Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Can we incorporate MRD assessment into clinical practice in AML?
Ossenkoppele G, Schuurhuis GJ, van de Loosdrecht A, Cloos J. Ossenkoppele G, et al. Among authors: schuurhuis gj. Best Pract Res Clin Haematol. 2019 Jun;32(2):186-191. doi: 10.1016/j.beha.2019.05.003. Epub 2019 May 10. Best Pract Res Clin Haematol. 2019. PMID: 31204000 Review.
MRD in AML: time for redefinition of CR?
Ossenkoppele G, Schuurhuis GJ. Ossenkoppele G, et al. Among authors: schuurhuis gj. Blood. 2013 Mar 21;121(12):2166-8. doi: 10.1182/blood-2013-01-480590. Blood. 2013. PMID: 23520326 Free article. No abstract available.
MRD in AML: it is time to change the definition of remission.
Ossenkoppele GJ, Schuurhuis GJ. Ossenkoppele GJ, et al. Among authors: schuurhuis gj. Best Pract Res Clin Haematol. 2014 Sep-Dec;27(3-4):265-71. doi: 10.1016/j.beha.2014.10.008. Epub 2014 Oct 15. Best Pract Res Clin Haematol. 2014. PMID: 25455276 Review.
MRD in AML: does it already guide therapy decision-making?
Ossenkoppele G, Schuurhuis GJ. Ossenkoppele G, et al. Among authors: schuurhuis gj. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):356-365. doi: 10.1182/asheducation-2016.1.356. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913502 Free PMC article. Review.
High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemia.
van den Ancker W, van Luijn MM, Chamuleau ME, Kelder A, Feller N, Terwijn M, Zevenbergen A, Schuurhuis GJ, van Ham SM, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA. van den Ancker W, et al. Among authors: schuurhuis gj. Leuk Res. 2014 Jun;38(6):691-3. doi: 10.1016/j.leukres.2014.03.014. Epub 2014 Mar 25. Leuk Res. 2014. PMID: 24731748
175 results